Vaccine candidate PF-07307405 (LB6V) demonstrated more than 70% efficacy in preventing Lyme disease in individuals aged five years and above -- The investigational vaccine candidate was well tolerated ...
An experimental six-strain Lyme disease vaccine developed by Pfizer has shown over 70% efficacy in individuals aged 5 years ...
The partners said the shot produced “clinically meaningful” efficacy despite missing its main study objective, a finding they ...
A roundtable on diagnostics and clinical needs of Lyme disease patients, clinicians and researchers, convened Dec. 15, 2025, ...
Michigan has seen cases skyrocket 168% in five years, but the new vaccine candidate offers hope with strong trial results and ...
Pfizer’s shot fell short of its initial trial goal, but with nearly half a million Americans infected each year, the company ...
As the spring season sets in and the weather starts to get warmer everyone wants to go outside to hike and take in nature but ...
Pfizer Inc. said its experimental Lyme disease vaccine was 73% effective against the tick-borne illness, a lackluster result ...
Less noticed has been Kennedy's promotion of a theory close to Long Island: Was Lyme disease developed at a government lab on Plum Island, which sits a mile off the North Fork? On his podcast in early ...
Pfizer and Valneva's Lyme disease vaccine has shown promising results in clinical trials, paving the way for regulatory ...
GRAND RAPIDS, Mich. (WOOD) — Emily Zoladz knew something was wrong with her son, Isaac, when the then-6-year-old began limping up the stairs. He had been sick with a fever for a few days when she ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results